Document:

Letter Agreement between Urologix, Inc. and Fred B. Parks

 EXHIBIT 10.1 
 UROLOGIX, INC. 
 February 22, 2008 
 Mr. Fred B. Parks 
 117 Portland Avenue 
 Minneapolis, MN 55401 
 Dear Fred: 
 This letter outlines our agreement regarding a change in your role with Urologix, Inc. (“Urologix”) and the termination of your employment with Urologix effective May 25, 2008 (the “Termination
Date”). 
 1. You are resigning as Chief Executive Officer, Chairman of the Board and a director as of February 25, 2008.

 Beginning February 26, 2008 and until the Termination Date, you will provide Urologix with certain advisory and transition services
with respect to matters or transactions of Urologix of which you have knowledge. You will fulfill these responsibilities under the direction and control of the Interim Chief Executive Officer or the Chief Executive Officer, as the case may be. You
will continue to be an active employee of Urologix through the Termination Date with all the benefits provided in connection with full-time employment, except that you will not accrue any vacation after February 25, 2008 and as otherwise
provided in this agreement. Beginning February 26, 2008, you will not be entitled to participate in any bonus or other incentive plan nor will you be eligible to receive stock options or other equity-based compensation. 
 2. The Employment Letter Agreement dated September 29, 2003, as amended July 19, 2004 (the “Employment Letter”) between you and
Urologix will become null and void and will be fully superseded by this letter beginning February 25, 2008, except that your obligations under that certain Agreement Regarding Employment, Inventions, Confidential Information and Non-Competition
(the “Non-Compete Agreement”) shall continue as provided therein. 
 3. After the Termination Date, if you and Urologix do not
extend your active employment with Urologix by written agreement: 
 (a) Urologix will pay you two-thirds of your base salary
(excluding bonus) in accordance with Urologix’ regular payroll practice for a period of up to 18 months after the Termination Date; 
 (b) with the first payroll following the Termination Date, you will receive a single lump-sum payment equal to any accrued unused paid time off; and 
 (c) you may continue health and certain other insurance coverage, according to state and federal law, beginning June 1, 2008. You
will receive a notice detailing your rights to 

  

 - 1 - 

 
continue insurance coverage under COBRA. Should you elect to continue that coverage, Urologix will continue to pay the employer’s portion of the group
insurance premiums and Urologix will pay your share of your group insurance premiums until the date that is the first to occur of: (i) 18 months from the date COBRA coverage begins, (ii) if you secure other employment during such 18 month
period that provides health insurance coverage, the first day of the start of such employment, or (iii) until your COBRA eligibility expires. You will be responsible for the payment of your premiums thereafter, as long as you remain eligible
under COBRA. 
 4. In partial consideration of your agreement to extend your severance pay over a 18-month period (as opposed to receiving it
over a 12-month period), your vested options as of the Termination Date shall continue to be exercisable after the Termination Date until the earlier of (i) November 26, 2009; or (ii) the expiration date of such options. 

5. Urologix agrees that it will not, directly or indirectly, make any derogatory comments to any person or entity about you. 
 In consideration for the benefits outlined above, you agree to the following: 
 1. You hereby release, agree not to sue and forever discharge Urologix, its past and present affiliates, officers, directors, agents, shareholders,
employees, insurers, indemnitors, successors or assigns (collectively, the “Releasees”) from any and all claims and causes of action, known or unknown, which you may have against any and all of them. Through this release, you extinguish
all causes of action against the Releasees occurring up to the date on which you sign this agreement including, but not limited to, any contract, commission, wage or benefit claims; intentional infliction of emotional distress, defamation or any
other tort claims; and all claims arising from any federal, state or municipal law or ordinance, including the Employee Retirement Income Security Act and the Family Medical Leave Act. This release extinguishes any potential claims of discrimination
arising from your employment with Urologix and termination of that relationship, including specifically any claims under the Minnesota Human Rights Act, the Americans With Disabilities Act, Title VII of the Civil Rights Act of 1964, the Older
Workers Benefit Protection Act and the Age Discrimination in Employment Act. This release does not extinguish any claims which arise against any Releasee after you sign this agreement and does not extinguish any claims for payments required under
this agreement. You certify that you (a) have not filed any claims, complaints or other actions against any Releasee; and (b) are hereby waiving any right to recover from any Releasee under any lawsuit or charge filed by you or any
federal, state or local agency on your behalf based upon any event occurring up to the date on which you sign this agreement. You are advised by Urologix to review your rights and responsibilities under this agreement with your own lawyer.

 2. On your last day of employment with Urologix, for no additional consideration provided to you other than the benefits provided herein,
you will execute and deliver to Urologix a further release of claims in the form of Exhibit A attached hereto. 
 3. You have 21 days to
review and consider this agreement. If you sign this agreement before 21 days have elapsed from the date on which you first receive it, then you will be voluntarily waiving your right to the full 21-day review period. 
  

 - 2 - 

 4. After signing this agreement, you have the right to rescind the release insofar as it extends to your
release of claims under the Age Discrimination in Employment Act and the Minnesota Human Rights Act within 15 calendar days of the date upon which you sign this agreement. You understand that if you desire to rescind the release as provided above,
you must put the rescission in writing and deliver it to Elissa Lindsoe, Urologix, Inc., 14405 Twenty-First Avenue North, Minneapolis, MN 55447, by hand or by mail, within the required period. If you deliver the rescission by mail, it must be
postmarked within the required period, properly addressed to Elissa Lindsoe and sent by certified mail, return receipt requested. If you effectively exercise this rescission right, Urologix may, at its option, either nullify this agreement or keep
it in effect in all respects other than as to your release of claims that you have rescinded. If Urologix chooses to nullify this agreement, neither you nor Urologix will have any further obligation to the other under this agreement. 
 5. You certify that you have returned all of Urologix’ property in your possession. 
 6. You agree that you will not, directly or indirectly, make any derogatory comments to any person or entity about Urologix, its past and present
affiliates, officers, directors, agents, shareholders and employees, or in any way interfere with or attempt to damage any of Urologix’ business or employment relationships. 
 7. You agree to abide by the terms and conditions of the Non-Compete Agreement and agree that Urologix may, in addition to other remedies provided under
the Non-Compete Agreement, withhold payments due to you under this agreement for violation of the Non-Compete Agreement. You also agree that the benefits provided under this agreement provide further and sufficient consideration for your obligations
under the Non-Compete Agreement. 
 This agreement and offer of benefits to you shall not in any way be construed as an admission of
liability by Urologix or as an admission that Urologix has acted wrongfully with respect to you. Urologix specifically denies and disclaims any such liability or wrongful acts. 
 In the event that any provision of this agreement is found to be illegal or unenforceable, such provision will be severed or modified to the extent
necessary to make it enforceable and, as so severed or modified, the remainder of this agreement shall remain in full force and effect. This agreement shall be binding upon the successors and assigns of Urologix, whether pursuant to merger, exchange
or sale of all or substantially all of the assets of Urologix and such successor shall assume Urologix’ obligations hereunder. 
 By
signing this agreement, you agree that you have entered into it voluntarily, without coercion, duress or reliance on any representations by any Urologix employee, agent or lawyer. 
  

 - 3 - 

 If this letter accurately reflects our understanding and agreement, please sign the original and copy and
return the original to me. The copy is for your file. 
 Sincerely, 
  

			
	UROLOGIX, INC.
		
		 	 /s/ Dan Starks

	By:	 	Dan Starks
	Its:	 	Compensation Committee Chair

 I have read and understand and agree to the terms and conditions set forth above and have signed this letter
agreement dated February 22, 2008 freely, voluntarily and with full knowledge and understanding of its meaning. 
  

					
	 /s/ Fred B. Parks
	 		 	Dated: February 25, 2008
	Fred B. Parks	 		 	

  

 - 4 - 

 EXHIBIT A 
 TO 
 LETTER AGREEMENT 
                     , 2008 
 Elissa Lindsoe 
 Urologix, Inc. 
 14405 Twenty-First Avenue North 
 Minneapolis, MN 55447 
 Dear Ms. Lindsoe: 
 I, the undersigned, in consideration of the benefits provided in that letter agreement from Urologix, Inc.
(“Urologix”) to me dated February 22, 2008 (the “Agreement”), hereby release, agree not to sue, and forever discharge Urologix, , its past and present affiliates, officers, directors, agents, shareholders, employees,
insurers, indemnitors, successors or assigns (collectively the “Releasees”), from any and all manner of claims, demands, actions, causes of action, administrative claims, liability, damages, claims for punitive or liquidated damages,
claims for attorneys’ fees, costs and disbursements, individual or class action claims, or demands of any kind whatsoever, I have or might have against them or any of them, whether known or unknown, in law or equity, contract or tort, arising
out of or in connection with my employment with Urologix, or the separation of that employment, or otherwise, and however originating or existing, from February     , 2008 through the date of this release. 
 This release includes any claims I may have for wages, bonuses, deferred compensation, vacation pay, separation pay and/or benefits, defamation, improper discharge
(based on contract, common law, or statute, including any federal, state or local statute or ordinance prohibiting discrimination or retaliation in employment), the Minnesota Human Rights Act, Title VII of the Civil Rights Act of 1964 as amended,
the Americans with Disabilities Act, the Older Workers Benefit Protection Act and the Age Discrimination in Employment Act, and any claim for discrimination or retaliation based on a protected class under state or federal law. I hereby waive any and
all relief not provided for in this release. 
 I affirm that I have not caused or permitted, and to the full extent permitted by law will not cause or
permit to be filed (to the extent that I am able to control such filing), any charge, complaint, or action of any nature or type against the Releasees, including but not limited to any action or proceeding raising claims arising in tort or contract,
or any claims arising under federal, state or local laws, including discrimination law. 
 I understand that I may rescind this release within seven
(7) calendar days after signing it to reinstate claims under the Age Discrimination in Employment Act and fifteen (15) calendar days after signing it to reinstate claims arising under the Minnesota Human Rights Act. In order to be 

  

 A-1 

 
effective, the rescission must (a) be in writing; and (b) delivered to Elissa Lindsoe, Urologix, Inc., 14405 Twenty-First Avenue North,
Minneapolis, MN 55447, by hand or by mail, within the required period; and (c) if delivered by mail, the rescission must be postmarked within the required period, properly addressed to Elissa Lindsoe and sent by certified mail, return receipt
requested. I understand that any rescission of this release shall not rescind or otherwise affect the release of claims contained in the Agreement and shall only reinstate claims as provided above arising from and after the date of the Agreement to
the date of this release. This release will be effective upon the expiration of the required period without rescission. I understand that if I rescind this release or the Agreement I will not continue to receive the benefits described in the
Agreement. 
  

	
	Very truly yours,
	
	  
	Fred B. Parks

  

 A-22007 Employee Stock Purchase Plan

 Exhibit 10.14 
 AS AMENDED DECEMBER 10, 2007 
 VMWARE, INC. 
 2007 EMPLOYEE STOCK PURCHASE PLAN 
 Section 1. Purpose of Plan 
 The VMware, Inc. 2007 Employee Stock Purchase Plan (the “Plan”) is intended to provide a method by which eligible employees of VMware, Inc.
(“VMware”) and its subsidiaries (collectively, the “Company”) may use voluntary, systematic payroll deductions to purchase VMware’s class A common stock, $.01 par value, (“stock”) and thereby acquire an interest in
the future of VMware. For purposes of the Plan, a subsidiary is any corporation in which VMware owns, directly or indirectly, stock possessing 50% or more of the total combined voting power of all classes of stock unless the Board of Directors of
VMware (the “Board of Directors”) determines that employees of a particular subsidiary shall not be eligible. 
 Section 2. Options to
Purchase Stock 
 Under the Plan, no more than 6,400,000 shares of stock are available for purchase (subject to adjustment as provided in
Section 16) pursuant to the exercise of options (“options”) granted under the Plan to employees of the Company (“employees”). The stock to be delivered upon exercise of options under the Plan may be either shares of the
Company’s authorized but unissued stock, or shares of reacquired stock, as the Board of Directors shall determine. 
 Section 3. Eligible Employees

 Except as otherwise provided in Section 20, each employee who has completed three months or more of continuous service in the employ
of the Company shall be eligible to participate in the Plan. Notwithstanding any other provision herein, individuals who are not contemporaneously classified as employees of VMware or an eligible subsidiary for purposes of VMware’s or
the applicable eligible subsidiary’s payroll system are not considered to be eligible employees and shall not be eligible to participate in the Plan. In the event any such individuals are reclassified as employees of VMware or an eligible
subsidiary for any purpose, including, without limitation, common law or statutory employees, by any action of any third party, including, without limitation, any government agency, or as a result of any private lawsuit, action or administrative
proceeding, such individuals shall, notwithstanding such reclassification, remain ineligible for participation. Notwithstanding the foregoing, the exclusive means for individuals who are not contemporaneously classified as employees of VMware or an
eligible subsidiary on the applicable payroll system to become eligible to participate in this Plan is through an amendment to this Plan, duly executed by VMware, which specifically renders such individuals eligible to participate herein.

 Section 4. Method of Participation 
 Generally 
 The periods January 1 to June 30 and July 1 to December 31 of each
year shall be option periods. Each person who will be an eligible employee on the first day of any option period may elect to participate in the Plan by executing and delivering, at least one business day prior to such day, a payroll deduction
authorization in accordance with Section 5. Such employee shall thereby become a participant (“participant”) on the first day of such option period and shall remain a participant until his or her participation is terminated as
provided in the Plan. 
 First Option Period 
 The first option period under the Plan will commence on the day on which VMware’s Form S-1 Registration Statement is declared effective by the Securities and Exchange Commission and will end on December 31, 2007. Any individual
who is an eligible employee immediately prior to the first option period shall be automatically enrolled in the first option period at an amount equal to 2% of his or her compensation. A participant in the first option period shall make payment for
the purchase of shares by (A) making a lump sum cash payment to the Company via check on or prior to December 31, 2007 for the amount of the purchase price for the shares being purchased (after which date an participant wishing to continue
participation in the Plan must participate on a payroll deduction basis unless the participant withdraws from the Plan under Section 10), or (B) electing, after the effective date of the Form S-8 for the issuance of stock under the Plan,
to have amounts directly withheld from the participant’s compensation pursuant to Section 5 (which percentage need not equal the amount specified above). 
 To the extent that a participant purchases shares in respect of the first option period by delivering a check to the Company, such delivery and purchase shall operate, unless the participant withdraws from the Plan
pursuant to Section 10, as an election by the participant to continue participating in the Plan on the payroll deduction basis described in Section 5 and the Company shall withhold from the participant’s compensation beginning with
the next option period at a contribution rate equal to the ratio that the aggregate purchase price paid for shares purchased bears to the participant’s total compensation during the first option period (which rate shall not exceed the
percentage specified in Section 5). 
 Section 5. Payroll Deductions 
 The payroll deduction authorization shall request withholding, at a rate of not less than 2% nor more than 15% from the participant’s compensation (subject to a maximum of $7,500 per option period), by means of
substantially equal payroll deductions over the option period; provided, however, that in the event any amount 

  

 2 

 
remaining in a participant’s withholding account at the end of an option period (which would be equal to a fractional share) is rolled over to the
opening balance in a participant’s withholding account for the next option period pursuant to Section 8 below (a “rollover”), such amount will be applied to the last payroll deduction for the next option period, thereby reducing
the amount of that payroll deduction; further provided that the maximum of $7,500 per option period shall be reduced by the amount of any rollover. For purposes of the Plan, “compensation” shall mean all cash compensation
paid to the participant by the Company. 
 A participant may only elect to change the withholding rate of his or her payroll deduction
authorization by written notice delivered to the Company at least one business day prior to the first day of the option period as to which the change is to be effective; provided, however, that the Company shall provide each participant with one
opportunity to change the level of his or her withholding rate during the first option period after the commencement of such period as contemplated by Section 4. Following delivery to the Company of any payroll deduction authorization or any
election to change the withholding rate of a payroll deduction authorization, appropriate payroll deductions or changes thereto shall commence as soon as reasonably practicable. All amounts withheld in accordance with a participant’s payroll
deduction authorization shall be credited to a withholding account for such participant. 
 Subject to the maximum $7,500 per option period
contribution, the Company shall permit each participant to contribute, by means of a one-time cash contribution, the amount of the payroll deductions that are returned to the participant from the EMC Corporation 1989 Employee Stock Purchase Plan as
a result of the participant’s participation in this Plan. Such contribution shall be credited to the participant’s withholding account, but no contribution may be made unless the Form S-8 registration statement with respect to the issuance
of stock under this Plan is effective. 
 Section 6. Grant of Options 
 Each person who is a participant on the first day of an option period shall as of such day be granted an option for such period. Such option shall be for the number of shares of stock to be determined by dividing
(a) the balance in the participant’s withholding account on the last day of the option period by (b) the purchase price per share of the stock determined under Section 7, and eliminating any fractional share from the quotient. In
the event that the number of shares then available under the Plan is otherwise insufficient, the Company shall reduce on a substantially proportionate basis the number of shares of stock receivable by each participant upon exercise of his or her
option for an option period and shall return the balance in a participant’s withholding account to such participant. In no event shall the number of shares of stock that a participant may purchase during any one option period under the Plan
exceed the number of shares determined by (a) multiplying fifteen percent (15%) of the amount of the participant’s compensation for the payroll period immediately preceding the date he or she is first granted an option for such option
period by the number of 

  

 3 

 
payroll periods from such date to the end of such option period, and (b) dividing that product by eighty-five percent (85%) of the fair market
value of a share of stock on such date. 
 Section 7. Purchase Price 
 The purchase price of stock issued pursuant to the exercise of an option shall be 85% of the fair market value of the stock at (a) the time of grant of the option or (b) the time at which the option is
deemed exercised, whichever is less. “Fair market value” shall mean the closing sales price per share of the stock on the principal securities exchange on which the stock is traded or, if there is no such sale on the relevant date, then on
the last previous day on which a sale was reported; if the stock is not listed for trading on a national securities exchange, the fair market value of the stock shall be determined in good faith by the Board of Directors. For purposes of the first
option period under the Plan, the fair market value of the stock at the time of the grant of the option will be the initial public offering price of the stock as set forth in VMware’s Form S-1 Registration Statement. 
 Section 8. Exercise of Options 
 If an employee is a
participant in the Plan on the last business day of an option period, he or she shall be deemed to have exercised the option granted to him or her for that period. Upon such exercise, the Company shall apply the balance of the participant’s
withholding account to the purchase of the number of whole shares of stock determined under Section 6, and as soon as practicable thereafter shall issue and deliver certificates for said shares to the participant. No fractional shares shall be
issued hereunder. Any balance accumulated in the participant’s withholding account that is not sufficient to purchase a full share shall be retained in such account for any remaining or subsequent option period, subject to early withdrawal by
the participant as provided in Section 10. Any other monies remaining in the participant’s withholding account under the Plan after the date of exercise shall be retuned to the participant or his or her beneficiary (as applicable) in cash,
without interest. 
 Notwithstanding anything herein to the contrary, the Company shall not be obligated to deliver any shares unless and
until, in the opinion of the Company’s counsel, all requirements of applicable federal and state laws and regulations (including any requirements as to legends) have been complied with, nor, if the outstanding stock is at the time listed on any
securities exchange, unless and until the shares to be delivered have been listed (or authorized to be added to the list upon official notice of issuance) upon such exchange, nor unless or until all other legal matters in connection with the
issuance and delivery of shares have been approved by the Company’s counsel. 
  

 4 

 Section 9. Interest 
 No interest will be payable on withholding accounts. 
 Section 10. Cancellation and Withdrawal 
 On or prior to June 15 or December 15, as the case may be with respect to any applicable option period, a participant who holds an option under
the Plan may cancel all (but not less than all) of his or her option by written notice delivered to the Company, in such form as the Company may prescribe. Any participant who delivers such written notice shall be deemed to have canceled his or her
option, terminated his or her payroll deduction authorization with respect to the Plan and terminated his or her participation in the Plan, in each case, as of the date of such written notice. In the event that any June 15 or December 15,
as the case may be with respect to the applicable option period, shall be a Saturday, Sunday or day on which banks in the State of Delaware are required or permitted to close, a participant may cancel his or her option by written notice given on or
prior to the last business day immediately preceding such date. Following delivery of any such notice, any balance in the participant’s withholding account will be returned to such participant as soon as reasonably practicable. Any participant
who has delivered such notice may elect to participate in the Plan in any future option period in accordance with the provisions of Section 4. With respect to the first option period, any participant who has not previously authorized payroll
deductions shall be considered to have withdrawn from such period if he or she fails to make payment as contemplated by Section 4. 
 Section 11.
Termination of Employment 
 Except as otherwise provided in Section 12, upon the
termination of a participant’s employment with the Company for any reason whatsoever, he or she shall cease to be a participant, and any option held by him or her under the Plan shall be deemed cancelled, the balance of his or her withholding
account shall be returned to him or her, and he or she shall have no further rights under the Plan. For purposes of this Section 11, a participant’s employment will not be considered terminated in the case of a transfer to the employment
of a subsidiary or to the employment of the Company. For purposes of the Plan, an individual’s employment relationship is still considered to be continuing intact while such individual is on sick leave, or other leave of absence approved for
purposes of this Plan by the Company or a subsidiary; provided however, that if such period of leave of absence exceeds ninety (90) days, and the individual’s right to reemployment is not guaranteed either by statute or by contract, the
employment relationship shall be deemed to have terminated on the ninety-first (91st) day of such leave. 
 Section 12. Death of Participant 
 In the event a
participant holds any option hereunder at the time his or her employment with the Company is terminated by his or her death, whenever occurring, 

  

 5 

 
then his or her legal representative), may, by a writing delivered to the Company on or before the date such option is exercisable, elect either (a) to
cancel any such option and receive in cash the balance in his or her withholding account, or (b) to have the balance in his or her withholding account applied as of the last day of the option period to the exercise of his or her option pursuant
to Section 8, and have the balance, if any, in such account in excess of the total purchase price of the whole shares so issued returned in cash. In the event his or her legal representative) does not file a written election as provided above,
any outstanding option shall be treated as if an election had been filed pursuant to subparagraph 12(a) above. 
 Section 13. Participant’s Rights
Not Transferable, etc. 
 All participants granted options under the Plan shall have the same rights and privileges. Each participant’s
rights and privileges under any option granted under the Plan shall be exercisable during his or her lifetime only by him or her, and shall not be sold, pledged, assigned, or otherwise transferred in any manner whatsoever except by will or the laws
of descent and distribution. In the event any participant violates the terms of this Section, any options held by him or her may be terminated by the Company and, upon return to the participant of the balance of his or her withholding account, all
his or her rights under the Plan shall terminate. 
 Section 14. Employment Rights 
 Neither the adoption of the Plan nor any of the provisions of the Plan shall confer upon any participant any right to continued employment with the
Company or a subsidiary or affect in any way the right of the Company to terminate the employment of such participant at any time. 
 Section 15. Rights
as a Shareholder 
 A participant shall have the rights of a shareholder only as to stock actually acquired by him or her under the Plan.

 Section 16. Change in Capitalization 
 In
the event of a stock dividend, stock split or combination of shares, recapitalization, merger in which the Company is the surviving corporation or other change in the Company’s capital stock, the number and kind of shares of stock or securities
of the Company to be subject to the Plan and to options then outstanding or to be granted hereunder, the maximum number of shares or securities which may be delivered under the Plan, the option price and other relevant provisions shall be
appropriately adjusted by the Board of Directors, whose determination shall be binding on all persons. In the event of a consolidation or merger in which the Company is not the surviving corporation or in the event of the sale or transfer of
substantially all the 

  

 6 

 
Company’s assets (other than by the grant of a mortgage or security interest), all outstanding options shall thereupon terminate, provided that prior to
the effective date of any such merger, consolidation or sale of assets, the Board of Directors shall either (a) return the balance in all withholding accounts and cancel all outstanding options, or (b) accelerate the exercise date provided
for in Section 8, or (c) if there is a surviving or acquiring corporation, arrange to have that corporation or an affiliate of that corporation grant to the participants replacement options having equivalent terms and conditions as
determined by the Board of Directors. 
 Section 17. Administration of Plan 
 The Plan will be administered by the Board of Directors. The Board of Directors will have authority, not inconsistent with the express provisions of the
Plan, to take all action necessary or appropriate hereunder, to interpret its provisions, and to decide all questions and resolve all disputes which may arise in connection therewith. Such determinations of the Board of Directors shall be conclusive
and shall bind all parties. 
 The Board may, in its discretion, delegate its powers with respect to the Plan to an Employee Benefit Plan
Committee or any other committee (the “Committee”), in which event all references to the Board of Directors hereunder, including without limitation the references in Section 17, shall be deemed to refer to the Committee. A majority of
the members of any such Committee shall constitute a quorum, and all determinations of the Committee shall be made by a majority of its members. Any determination of the Committee under the Plan may be made without notice or meeting of the Committee
by a writing signed by all of the Committee members. 
 Section 18. Amendment and Termination of Plan 
 The Board of Directors may at any time or times amend the Plan or amend any outstanding option or options for the purpose of satisfying the requirements
of any changes in applicable laws or regulations or for any other purpose which may at the time be permitted by law, provided that (except to the extent explicitly required or permitted herein) no such amendment will, without the approval of the
shareholders of the Company, (a) increase the maximum number of shares available under the Plan, (b) reduce the option price of outstanding options or reduce the price at which options may be granted, (c) change the conditions for
eligibility under the Plan, or (d) amend the provisions of this Section 18 of the Plan, and no such amendment will adversely affect the rights of any participant (without his or her consent) under any option theretofore granted.

 The Plan may be terminated at any time by the Board of Directors, but no such termination shall adversely affect the rights and privileges
of holders of the outstanding options. 
  

 7 

 Section 19. Approval of Shareholders 
 The Plan shall be subject to the approval of the shareholders of the Company, which approval shall be secured within twelve months after the date the Plan is adopted by the Board of Directors. Notwithstanding any
other provisions of the Plan, no option shall be exercised prior to the date of such approval. 
 Section 20. Limitations 
 Notwithstanding any other provision of the Plan: 
 (a) An employee shall not be eligible to receive an option pursuant to the Plan if, immediately after the grant of such option to him or her, he or she would (in accordance with the provisions of Sections 423 and 424(d) of the Internal
Revenue Code of 1986, as amended (the “Code”)) own or be deemed to own stock possessing 5% or more of the total combined voting power or value of all classes of stock of the employer corporation or of its parent or subsidiary corporation,
as defined in Section 424 of the Code Internal Revenue Code of 1986, as amended (the “Code”). 
 (b) No employee shall be
granted an option under this Plan that would permit his or her rights to purchase shares of stock under all employee stock purchase plans (as defined in Section 423 of the Code) of VMware or any subsidiary or parent corporation to accrue at a
rate which exceeds $25,000 in fair market value of such stock (determined at the time the option is granted) for each calendar year during which any such option granted to such employee is outstanding at any time, as provided in Section 423 of
the Code. 
 (c) No employee shall be granted an option under this Plan that would permit him or her to withhold more than $7,500 in each
option period or $15,000 per calendar year, less the amount of any rollover. 
 (d) No employee whose customary employment is 20 hours or
less per week shall be eligible to participate in the Plan. 
 (e) No independent contractor shall be eligible to participate in the Plan.

  

 8 

 Section 21. Jurisdiction and Governing Law. 
 The Company and each participant in the Plan submit to the exclusive jurisdiction and venue of the federal or state courts of Delaware to resolve issues
that may arise out of or relate to the Plan or the same subject matter. The Plan shall be governed by the laws of Delaware, excluding its conflicts or choice of law rules or principles that might otherwise refer construction or interpretation of
this Plan to the substantive law of another jurisdiction. 
 Section 22. Compliance with Foreign Laws and Regulations. 
 Notwithstanding anything to the contrary herein, the Board, in order to conform with provisions of local laws and regulations in foreign countries in
which the Company or its subsidiaries operate, shall have sole discretion to (i) modify the terms and conditions of options granted to participants employed outside the United States; (ii) establish sub-plans with modified enrollment or
exercise procedures and/or establish such other modifications as may be necessary or advisable under the circumstances presented by local laws and regulations; and (iii) take any action which it deems advisable to obtain, comply with or
otherwise reflect any necessary governmental regulatory procedures, exemptions or approvals with respect to the Plan or any sub-plan established hereunder.” 
  

 9

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00137-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00137-of-00352.parquet"}]]